Understanding MS Progression: The Importance of Treatment Adherence
Date: June 25, 2018
Time:
5:00PM PT / 6:00PM MT / 7:00PM CT / 8:00PM ET
Location: Webinar
Presenters:
Carrie M Hersh. DO, MSc
MSAA (MS Association of America)
Research continues to show that patient use of FDA-approved disease modifying therapies (DMTs) for multiple sclerosis reduces the frequency and severity of relapses, reduces the development of new areas of inflammation as seen on an MRI, and may delay disease progression and/or disability. Unfortunately numerous challenges are associated with starting and adhering to a DMT, which can adversely affect one’s health.
MSAA invites you to register for our free live webinar Understanding MS Progression: The Importance of Treatment Adherence on Monday, June 25, 2018 from 8:00 – 9:00 pm Eastern. In this live, one-hour webinar, MS expert Dr. Carrie Hersh will:
- Provide a thorough understanding of MS disease progression
- Highlight research findings to support the critical importance of MS treatment adherence
- Identify common challenges and barriers for non-adherence
- Offer effective strategies and tools designed to offset these barriers and help maintain treatment adherence
Following the presentation, participants will have the opportunity to engage in a Q & A session with Dr. Hersh from typed questions submitted through the webinar’s live chat feature.
